Hatch BioFund, LP — Form D/A
Hatch BioFund, LP of DOYLESTOWN, PA, a pooled investment fund, filed a Form D amendment with the SEC on 2023-05-03. The offering totals $50.0M, of which $30.6M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2023-05-03
- Form: D/A
- Accession: 0001875934-23-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1, 3C.7
- Total offering: $50.0M
- Amount sold: $30.6M
- Remaining: $19.4M
- Investors: 5
- Date of first sale: 2021-07-31
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-408328
Issuer
- Name: Hatch BioFund, LP
- CIK: 0001875934
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 3805 OLD EASTON ROAD, DOYLESTOWN, PA, 18902
- Phone: 215-589-6310
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| n/a Hatch BioFund GP, LLC | Director | Doylestown, PA |
| n/a Hatch BioFund Management, LLC | Director | Doylestown, PA |
| Lorenzo Pellegrini | Executive Officer | Princeton, NJ |
| Vladimir Walko | Director | Doylestown, PA |
Other filings by this issuer (1)
More